Characteristics associated with suboptimal viral suppression at delivery in human immunodeficiency virus-1-infected pregnant women

American Journal of Obstetrics and Gynecology

Volumn 193, Issue 3 SUPPL., 2005, Pages 1266-1269

  Louis, Judette M ^a   Buhari, Mudathiru A ^a   Blackwell, Sean C ^a   Refuerzo, Jerrie ^a   Allen, Dianne ^a   Gonik, Bernard ^a   Jones, Theodore B ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Human immunodeficiency virus; Pregnancy; Prenatal care; Substance abuse; Viral load

Indexed keywords

ADULT; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DELIVERY; DEMOGRAPHY; FEMALE; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; URBAN AREA; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; LOGISTIC MODELS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL LOAD;

EID: 24644476991     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.06.052     Document Type: Conference Paper

References (12)

1. E.R. Cooper, M. Charurat, L. Mofenson, I.C. Hanson, J. Pitt, and C. Diaz Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of perinatal HIV-1 transmission J Acquir Immune Defic Syndr 29 2002 484 494
2. L. Mandelbrot, A. Landreau-Mascaro, C. Rekacewicz, A. Berrebi, J.L. Benifla, and M. Burgard Lamivudine-zidovudine combination for prevention of maternal infant transmission of HIV-1 JAMA 285 2001 2083 2093
3. P.M. Garcia, L.A. Kalish, J. Pitt, H. Minkoff, T.C. Quinn, and S.K. Burchett Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission N Engl J Med 341 1999 394 402
4. E.M. Connor, R.S. Sperling, R. Gelber, P. Kiselev, G. Scott, and M.J. O' Sullivan Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment N Engl J Med 331 1994 1173 1180
5. A.N. Phillips, S. Staszewski, R. Weber, O. Kirk, P. Francioli, V. Miller, and P. Vernazza HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load JAMA 286 2001 2560 2567
6. M.A. Polis, I.A. Sidorov, C. Yoder, S. Jankelevich, J. Metcalf, and B.U. Mueller Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy Lancet 358 2001 1760 1765
7. M.P. Webber, E.E. Schoenbaum, M.N. Gourevitch, D. Buono, and R.S. Klein A prospective study of HIV disease progression in female and male drug users AIDS 13 1999 257 262
8. W.G. Powderly, M.S. Saag, S. Chapman, G. Yu, B. Quart, and N.J. Clendeninn Predictors of optimal virological response to potent antiretroviral therapy AIDS 13 1999 1873 1880
9. C.D. Zorrilla, L.E. Santiago, D. Knubson, K. Liberatore, G. Estronza, and O. Colon Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV Cell Mol Biol (Noisy-le-grand) 9 2003 1187 1192
10. R.M. Novak, L. Chen, R.D. MacArthur, J.D. Baxter, K. Huppler Hullsiek, and G. Peng Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy Clin Infect Dis 40 2005 468 474
11. G. Jourdain, N. Ngo-Giang-Huong, S. LeCoeur, C. Bowonwatanuwong, P. Kantipong, and P. Leechanachai Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy N Engl J Med 351 2004 229 240
12. J.G. Bartlett Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents 2004 US Department of Health and Human Services Washington, DC